Larson Financial Group’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Larson Financial Group's NUVB Position: Q3 2026 in Review
Larson Financial Group increased its Nuvation Bio (NUVB) stake by 111% in Q3 2026, buying an estimated $194 and bringing the position to 59 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #3652.
Larson Financial Group first reported a position in NUVB in Q3 2024 and has held it in 7 quarters since. The position peaked at $20K in Q3 2025. 254 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Larson Financial Group held 59 shares of Nuvation Bio worth $330 as of Q3 2026.
- Larson Financial Group bought 31 Nuvation Bio shares in Q3 2026, an estimated $194.
- Nuvation Bio made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3652 holding.
- Larson Financial Group first reported a position in Nuvation Bio in Q3 2024 and has held it in 7 quarters since.
- Larson Financial Group's Nuvation Bio position peaked at $20K in Q3 2025.
- 254 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.